Drug Name:Compound Anisodine Hydrobromide Injection
Product License Number:Guoyaozhunzi H20000495
Drug Description:This product is indicated for the treatment of the ischemic disorders of optic nerve, retina, and choroid.
Pharmaceutical ingredients
This product is a compound preparation. Each ampoule contains 0.1mg of anisodine hydrobromide and 10mg of procaine hydrochloride.
Drug Specifications

 

2ml: 0.2 mg of anisodine hydrobromide, 20mg of procaine hydrochloride

Drug application
[Usage and dosage]
This product should be injected subcutaneously beside the superficial temporal artery of diseased side. The recommended dosage is 2 ml (one ampoule) once daily (for acute or severe cases, an additional per bulbar injection should be given once daily). Fourteen injections compose one course of treatment. 2-4 courses of treatment may be required according to conditions of different patients.